Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SIK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NMB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCML1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EVL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLHL13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BBS5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDELC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRPV2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DTX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNDIG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPARCL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EML1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BHLHB9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on